In this week's edition, risk for cognitive decline is associated with older COVID-19 survivors; a study validates an FDA-approved blood test for traumatic brain injury; and more.

Read the full coverage here:

Risk for cognitive decline associated with older COVID-19 survivors

Study validates FDA-approved blood test for traumatic brain injury

VA hospital telestroke networks improve treatment, lower ED transfer rate

Lower left atrial function associated with higher risk for dementia

Rates of neurological events higher with SARS-CoV-2 infection than with COVID-19 vaccine

References:

Liu YH, et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.0461.

Papa L, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.1302.

Lyerly M, et al. Neurology. 2022;doi:10.1212/WNL.0000000000200143.

Wang W, et al. JAMA. 2022;doi:10.1001/jama.2022.2518

Li X, et al. BMJ. 2022;doi:10.1136/bmj-2021-068373.